Sunday, 29 June 2014

FDA Approves Afrezza to Treat Diabetes

FDA Approves Afrezza to Treat Diabetes
"Afrezza is a new treatment option for patients with diabetes requiring mealtime insulin," said Jean-Marc Guettier, M.D., director of the Division of Metabolism and Endocrinology Products in the FDA’s Center for Drug Evaluation and Research.


CLICK HERE for the original article.